ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Lepu Biopharma (2157.HK) announces 2025 interim results ACN Newswire
August 21, 2025Focusing on the field of tumor treatment, innovative biopharmaceutical company Lepu Biopharma Co., Ltd. (Lepu Biopharma or the Company, stock code: 2157.HK) announced its interim results for the first half of 2025. -
Lepu Biopharma Announces Proposed Listing on the Main Board of the Hong Kong Stock Exchange PharmaSources.com
February 18, 2022The biopharmaceutical company focusing on oncology therapeutics - Lepu Biopharma Co., Ltd. ("Lepu Biopharma" or the "Company", stock code: 2157), today announced the proposed listing...
Pharma Sources Insight July 2025
